August 1, 1998Journal of Hypertension
Long-term cost and life-expectancy consequences of hypertension
Why the study?
Does severe hypertension reduce life expectancy and increase long-term costs compared to normotension in adults aged 25-59?
Population
10,284 men and women aged 25-59 years from the provinces of Kuopio and North Karelia in eastern Finland
Comparison
Mild hypertension and severe hypertension vs Normotensive (diastolic blood pressure < 95 mmHg)
Design
Cohort
Follow-up
19 years
Authors
Discussion
Loading...
Member takes
Implication
May warrant closer monitoring in adults 25-59; leaves open whether intensified control alters longevity or costs.
Structured PICO
Does severe hypertension reduce life expectancy and increase long-term costs compared to normotension in adults aged 25-59?
P
Population
10,284 men and women aged 25-59 years from the provinces of Kuopio and North Karelia in eastern Finland
I
Intervention
Mild hypertension (diastolic blood pressure 95-104 mmHg) and severe hypertension (diastolic blood pressure > 104 mmHg)
C
Comparator
Normotensive (diastolic blood pressure < 95 mmHg)
O
Outcome
Numbers of years of life and years of work lost, the cost of drugs and hospitalization, and the value of productivity lost due to disability and premature mortalityhard clinical
Severe hypertension is associated with significant reductions in life expectancy and substantial increases in healthcare and productivity costs over 19 years.
Cite This Study
Kiiskinen et al. (1998) studied this question.